Markets:

Overview

News

Currencies

International

Treasuries

U.S. Small Cap Portfolio: ETF Class Shares (NY:DFAS)

78.24 +0.98 (+1.27%)

Delayed Quote Updated: 3:35 PM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about U.S. Small Cap Portfolio: ETF Class Shares

Why Is TGEN Stock Rising After Hours? ↗

March 17, 2026

Tecogen reported full year 2025 results on Tuesday, with revenue beating Wall Street expectations.

Via Stocktwits

Eastman Kodak Stock Rallies After-Hours As Q4 Revenue Jumps On Strong Segment Performance ↗

March 12, 2026

Kodak reported consolidated revenues of $290 million in the fourth quarter of 2025, compared with $266 million in the year-ago period, an increase of $24 million or 9%.

Via Stocktwits

Topics Retirement

Exclusive: Opendoor CEO Reveals Company’s Own Mortgage Product Is In Beta Phase, Criticizes Fed On Interest Rates ↗

February 20, 2026

OPEN’s CEO Kaz Nejatian said that truflation is a much better measure of inflation and no one who invests their own money looks at BLS data.

Via Stocktwits

Topics Earnings Economy

RXT Stock Soared 275% Today – What’s The Connection With Palantir? ↗

February 18, 2026

The company announced it would help businesses rapidly deploy Palantir’s Foundry and Artificial Intelligence Platform.

Via Stocktwits

Topics Artificial Intelligence

B.Riley Stock Soars Nearly 40% - What’s Behind The Move? ↗

January 14, 2026

Via Stocktwits

Why Did FuelCell Stock Rocket 35% Today? ↗

December 18, 2025

Via Stocktwits

FOSL Stock Plunges After Extending Exchange Offer For Its Senior Notes Due 2026 ↗

October 16, 2025

Via Stocktwits

RXT Stock Soars 157% Pre-Market – What’s The Connection To Palantir? ↗

February 18, 2026

The company announced it would help businesses rapidly deploy Palantir’s Foundry and Artificial Intelligence Platform.

Via Stocktwits

Topics Artificial Intelligence

Why Is Cineverse Stock Rising Despite Missing Q3 Revenue and Earnings Estimates? ↗

February 17, 2026

The company said it expects $115 million to $120 million in revenue for fiscal year 2027, however analysts on average were expecting the revenue of $85.23 million, as per data from fiscal.ai.

Via Stocktwits

From Bitcoin Mining To AI: What’s Driving BitFarms’ Stock Jump Today? ↗

January 02, 2026

BitFarms agreed to sell its 70 MW site in Paraguay to a crypto infrastructure fund for $30 million as part of its plans to fully exit LatAm.

Via Stocktwits

Topics Artificial Intelligence

One Stop Systems Stock Rises After Hours On Selling Bressner To Focus On Higher-Growth Segments ↗

December 30, 2025

Hardware manufacturer OSS sold Bressner, which it acquired in October 2018, for $22.4 million to Hiper Euro GMBH on Tuesday.

Via Stocktwits

Topics Artificial Intelligence

TrueCar Shares Soar Following $227M Go-Private Deal ↗

October 15, 2025

Via Stocktwits

Cassava Sciences Stock On Track For Worst Day In About 9 Months — What’s Driving Today’s Selloff? ↗

December 19, 2025

FDA placed a clinical hold on the proposed proof-of-concept clinical trial for Simufilam in tuberous sclerosis complex -related epilepsy earlier this week.

Via Stocktwits

Kezar Life Sciences Stock Hit With Downgrades And Price Target Cuts: Retail Keeps Hopes Alive ↗

October 17, 2025

Kezar announced on Thursday that it was unable to align with the FDA on a potential registrational clinical trial of Zetomipzomib in patients with relapsed and refractory autoimmune hepatitis.

Via Stocktwits

Topics Workforce

Cellectar Biosciences Stock Drops 17% On $5.8M Fundraise: Retail Awaits An ‘Impending’ Rally ↗

October 07, 2025

The company announced that it now intends to utilize the net proceeds for working capital and general corporate purposes, in addition to funding the early-stage trial of its CLR 125 compound in...

Via Stocktwits

Topics Supply Chain

Lyra Therapeutics To Conduct One More Trial For Chronic Rhinosinusitis Treatment Candidate ↗

October 06, 2025

The company stated that the design of the new trial will be based on the learnings from the previous trials, in addition to FDA feedback.

Via Stocktwits

Cash Cow Alert: 3 Small-Cap Stocks Making Big Profits ↗

July 15, 2024

Profitable small-cap stocks are still out there, even if finding profitability in small-cap stocks isn’t as easy as it once was.

Via InvestorPlace

3 Small-Cap Stocks to Juice Your Portfolio’s Long-Term Returns ↗

July 04, 2024

Owning too many small-cap stocks could be bad for your health. That doesn’t mean you shouldn’t own any. Here are three to buy now.

Via InvestorPlace

Small-Cap ETFs Enjoy Record Inflows Due To Optimistic Retail Investors: Is This The Decade Of 10% Annual Returns? ↗

February 21, 2024

Small-cap ETFs see record-breaking inflows, driven by retail investors. Bank of America predicts bullish outlook for 2024.

Via Benzinga

Topics ETFs